Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Evidence for hearing screens found lacking:

This article was originally published in Clinica

Executive Summary

There is insufficient evidence to recommend for or against routinely screening newborns for hearing loss. This is the finding of the US Preventative Services Task Force (USPSTF), a panel of independent, private-sector experts in preventative and primary care. The USPSTF reached its conclusion based on a report by the Evidence-based Practice Center at Oregon Health and Science University. The panel says that there good evidence that universal screening leads to earlier identification and treatment of infants with hearing loss. However, research to determine whether earlier treatment resulting from screening leads to long-term improvements in language skills have so far been inconclusive.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT073876

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel